These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1087566)

  • 1. Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.
    Chalmers PJ; Matthews N; Nairn RC
    Br J Cancer; 1976 Dec; 34(6):645-50. PubMed ID: 1087566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
    Matthews N; Chalmers PJ; Flannery GR; Nairn RC
    Br J Cancer; 1976 Mar; 33(3):279-89. PubMed ID: 773397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.
    Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
    Br J Cancer; 1973 Oct; 28(4):293-8. PubMed ID: 4202457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
    Br J Cancer; 1973 Aug; 28(2):118-22. PubMed ID: 4542343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.
    Höffken K; Price MR; Moore VE; Baldwin RW
    Int J Cancer; 1978 Nov; 22(5):576-82. PubMed ID: 214404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.
    Basham C; Currie GA
    Br J Cancer; 1974 Mar; 29(3):189-98. PubMed ID: 4830142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 125 I-labeled rat transplantation alloantibody. I. Preparation.
    Shumak KH; Batchelor JR; Watts HG
    Transplantation; 1973 Jan; 15(1):70-9. PubMed ID: 4575923
    [No Abstract]   [Full Text] [Related]  

  • 13. Spleen-cell reactivity against transplanted neurogenic rat tumors induced by ethylnitrosourea: uncovering of tumor specificity after removal of complement-receptor-bearing lymphocytes.
    Cornain S; Carnaud C; Silverman D; Klein E; Rajewsky MF
    Int J Cancer; 1975 Aug; 16(2):301-11. PubMed ID: 50296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adult thymectomy on tumour immunity in mice.
    Takei F; Levy JG; Kilburn DG
    Br J Cancer; 1978 May; 37(5):723-31. PubMed ID: 306831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor-specific cytotoxic and neutralizing factor in rats immunized with ascites hepatoma induced by azo dyes.
    El-Asfahani AM; Mizuno D; Hashimoto Y; Ishidate M; Nishioka K
    Gan; 1975 Feb; 66(1):11-9. PubMed ID: 168113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.
    Currie GA; Gage JO
    Br J Cancer; 1973 Aug; 28(2):136-46. PubMed ID: 4730177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.
    Farram E; Festenstein H; de Giorgi L
    Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of cell-mediated cytotoxicity to a rat lymphoma. I. Stimulation of non-T-cell cytotoxicity in vivo by tumour cells.
    Dawkins HJ; Shellam GR
    Int J Cancer; 1979 Aug; 24(2):235-43. PubMed ID: 489165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies.
    Ran M; Klein G; Witz IP
    Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.